This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: BHI GNC LO SBGI STZ


Baker Hughes (BHI - Get Report) was upgraded at Goldman Sachs to buy from neutral. Twelve-month price target is $72. Company should benefit from an improving pressure pumping market, Goldman said.

Bellatrix Exploration (BXE) was downgraded to sell at TheStreet Ratings.

Commvault (CVLT) was upgraded at Mizuho to buy from neutral. Twelve-month price target is $80. Company can continue to gain market share, Mizuho said.

Ever-Glory International (EVK) was upgraded to buy at TheStreet Ratings.

Facebook (FB) was downgraded at Argus to hold from buy. Valuation call, Argus said.

Must Read: Analysts' Actions: DHT LOW NUE TEVA X

FEI (FEIC) was downgraded at DA Davidson to neutral from buy. Valuation call, based on a 12-month price target of $105.

GNC (GNC) was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $51. Company has lower sales visibility, Credit Suisse said.

Lorillard (LO) was upgraded at Goldman Sachs to buy. Company is attractive, based on a sum-of-the-parts valuation, Goldman Sachs said.

Martin Midstream Partners (MMLP) was upgraded at UBS to buy from neutral. Alinda Capital Partners acquisition LT positive, UBS said. Twelve-month price target is $46. Buy rating.

Netscout (NTCT) was downgraded at DA Davidson to neutral from buy. Valuation call, as the stock is up 35% year to date, DA Davidson said. Twelve-month price target is $40.

Patterson-UTI (PTEN) was upgraded at Goldman Sachs to buy from neutral. Company was also placed on the Conviction List, Goldman said. Twelve-month price target is $37. Expect higher onshore pricing in North America, Goldman said.

Regeneron (REGN) was upgraded at Citigroup to buy. See a lot of value embedded in the clinical pipeline, Citigroup said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
LO $0.00 0.00%
BHI $44.58 -2.10%
AAPL $94.06 -1.20%
FB $117.51 0.07%
GOOG $697.14 0.69%


Chart of I:DJI
DOW 17,659.34 -91.57 -0.52%
S&P 500 2,048.00 -15.37 -0.74%
NASDAQ 4,718.88 -44.3440 -0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs